M.K. Reinders

A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day in patients with gout

M.K. Reinders, C.J. Haagsma, Tim Jansen et al. · Annals of the Rheumatic Diseases · 2008 · 184 citations

Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol

M.K. Reinders, Eric N. van Roon, Tim Jansen et al. · Annals of the Rheumatic Diseases · 2008 · 159 citations

Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients

M.K. Reinders, Eric N. van Roon, P. M. Houtman et al. · Clinical Rheumatology · 2007 · 91 citations · Full text

Urology, Medicine, Gouty Arthritis +4

Rasburicase treatment in severe tophaceous gout: a novel therapeutic option

J. D. Moolenburgh, M.K. Reinders, Tim Jansen · Clinical Rheumatology · 2005 · 54 citations

Rheumatology, Urology, Gouty Arthritis +4

A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection

M.K. Reinders, Lars C. Nijdam, Eric N. van Roon et al. · Journal of Pharmaceutical and Biomedical Analysis · 2007 · 34 citations · Full text

Simple Method, Medicine, Bioanalysis +10